News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,644 Results
Type
Article (41194)
Company Profile (260)
Press Release (658190)
Section
Business (206181)
Career Advice (2032)
Deals (35712)
Drug Delivery (89)
Drug Development (81297)
Employer Resources (169)
FDA (16257)
Job Trends (15018)
News (348221)
Policy (32931)
Tag
Academia (2614)
Alliances (50103)
Alzheimer's disease (1312)
Approvals (16226)
Artificial intelligence (185)
Bankruptcy (358)
Best Places to Work (11699)
Biotechnology (181)
Breast cancer (216)
Cancer (1612)
Cardiovascular disease (125)
Career advice (1697)
Cell therapy (327)
Clinical research (65267)
Collaboration (620)
Compensation (332)
COVID-19 (2606)
C-suite (145)
Data (1523)
Diabetes (198)
Diagnostics (6410)
Earnings (85602)
Employer resources (146)
Events (111390)
Executive appointments (534)
FDA (17086)
Funding (567)
Gene therapy (226)
GLP-1 (647)
Government (4400)
Healthcare (18881)
Infectious disease (2710)
Inflammatory bowel disease (114)
Interviews (313)
IPO (16498)
Job creations (3748)
Job search strategy (1446)
Layoffs (433)
Legal (7996)
Lung cancer (241)
Manufacturing (224)
Medical device (13312)
Medtech (13317)
Mergers & acquisitions (19532)
Metabolic disorders (521)
Neuroscience (1698)
NextGen: Class of 2025 (6547)
Non-profit (4530)
Northern California (1945)
Obesity (295)
Opinion (193)
Parkinson's disease (113)
Patents (138)
People (57380)
Phase I (20336)
Phase II (28726)
Phase III (21405)
Pipeline (651)
Postmarket research (2583)
Preclinical (8682)
Radiopharmaceuticals (241)
Rare diseases (305)
Real estate (6107)
Regulatory (22150)
Research institute (2375)
Resumes & cover letters (350)
Southern California (1686)
Startups (3613)
United States (17485)
Vaccines (601)
Weight loss (202)
Date
Today (141)
Last 7 days (603)
Last 30 days (2818)
Last 365 days (34913)
2025 (2950)
2024 (35424)
2023 (40335)
2022 (51425)
2021 (56017)
2020 (54503)
2019 (46969)
2018 (35324)
2017 (32520)
2016 (31979)
2015 (38001)
2014 (31864)
2013 (26985)
2012 (29107)
2011 (29783)
2010 (27820)
Location
Africa (731)
Arizona (208)
Asia (38254)
Australia (6258)
California (4462)
Canada (1629)
China (373)
Colorado (204)
Connecticut (211)
Europe (82266)
Florida (646)
Georgia (157)
Illinois (441)
Indiana (250)
Maryland (709)
Massachusetts (3434)
Michigan (190)
Minnesota (329)
New Jersey (1267)
New York (1283)
North Carolina (822)
Northern California (1945)
Ohio (166)
Pennsylvania (1041)
South America (1123)
Southern California (1686)
Texas (653)
Utah (133)
Washington State (443)
699,644 Results for "cdi laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acurx Receives Positive Regulatory Guidance from EMA for Ibezapolstat Phase 3 Program for C. Difficile Infection (CDI)
January 6, 2025
·
13 min read
Policy
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView™ Monitoring System
Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, announced that the U.S. Food and Drug Administration has granted 510 clearance for the CDI OneView Monitoring System.
May 28, 2024
·
3 min read
Press Releases
Cocrystal Pharma Reports Phase 1 Results with Oral, Broad-Acting Antiviral Drug CDI-988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections
January 9, 2025
·
6 min read
Business
Barney E. Saunders Ph.D. has been appointed Chief Executive Officer of CDI Laboratories
CDI Laboratories Inc., the Seromics™ company, announced that Barney E. Saunders Ph.D. has been appointed Chief Executive Officer.
August 2, 2023
·
2 min read
Press Releases
Cocrystal Pharma Advances Oral Pan-Viral Protease Inhibitor CDI-988 into Phase 1 Multiple-Ascending Dose Cohorts
September 27, 2024
·
5 min read
Drug Development
Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
Acurx Pharmaceuticals, Inc. today announced positive extended clinical cure (ECC) data for ibezapolstat (IBZ), its lead antibiotic candidate, from the Company’s recently completed Phase 2b clinical trial in patients with CDI.
January 29, 2024
·
13 min read
Drug Development
Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
Acurx Pharmaceuticals, Inc. today announced positive comparative microbiology and microbiome data for ibezapolstat, its lead antibiotic candidate, from the Company’s recently completed Phase 2b clinical trial in patients with CDI.
January 17, 2024
·
14 min read
Press Releases
Acurx Announces New Bile Acid and Microbiome Analyses from Ph2b Trial of Ibezapolstat in CDI Patients Presented at IDWeek Scientific Conference
October 21, 2024
·
14 min read
Press Releases
Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 Analogues
September 27, 2024
·
14 min read
Press Releases
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
January 17, 2025
·
1 min read
1 of 69,965
Next
